Increased multimodality treatment options has improved survival for Hepatocellul
- This topic has 0 replies, 1 voice, and was last updated 5 years ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Increased multimodality treatment options has improved survival for Hepatocellular carcinoma but poor survival for biliary tract cancers remains unchanged.
https://www.ncbi.nlm.nih.gov/pubmed/31014988
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.